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ABSTRACT 
INTRODUCTION. The purpose of this paper was to report the long-term outcome of a living-related limbal allograft 
transplantation followed by penetrating keratoplasty in a patient with severe bilateral stem cell deficiency.
MATERIALS AND METHODS. A 50-year-old woman presented with extensive bilateral stem cell deficiency secondary 
to ocular acid burn on both eyes. Visual acuity was counting fingers at 30 cm on the right eye and counting fingers at 
1 m Snellen line on the left. Limbal allograft transplantation on the right eye from a first-degree living-related relative 
was performed. The recipient was prepared by removing the abnormal corneal epithelium and vascularised pannus 
of the right eye under general anaesthesia. Two limbal allografts (mean length of 2–3 corresponding anatomic posi-
tions on the recipient). Postoperatively, the host received systemic immunosuppression (steroids and cyclosporine). 
RESULTS. The cornea of the right eye achieved reepithelialisation within two weeks after surgery, followed by re-
duction in vascularity in eight weeks time. After one year of regular follow up, the corneal surface remained stable 
whereas the stroma was opaque and the vision was low. Therefore, the patient underwent penetrating keratoplasty 
on the same eye. After the surgery the corneal graft was clear and the visual acuity on the right eye improved to 
20/50 Snellen line. No graft rejection occurred after a five-year follow-up. 
CONCLUSION. Living-related limbal allograft transplantation is a good alternative option in cases of total bilateral 
stem cell deficiency whenever a conjunctival limbal autograft transplantation is not possible. 
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INTRODUCTION 
Limbal stem cells are responsible for the homeostasis 
of the corneal epithelium and probably reside in the basal 
layer of the palisades of Vogt [1]. When there is need for 
tissue regeneration, the stem cells start to divide [2, 3]. 
The basal limbal epithelium contains the unique and least 
differentiated cells of corneal epithelium [4]. In the case of 
limbal stem cell dysfunction or deficiency due to injury, 
the conjunctiva must reepithelialise the corneal surface. 
This process is prolonged and does not allow the pro-
duction of a normal phenotypic corneal epithelium [5]. 
Limbal stem cell deficiency can be defined as primary 
and secondary. Primary deficient states are caused by an 
insufficient stromal microenvironment to keratitis asso-
ciated with multiple endocrine deficiencies and neuro-
trophic keratopathy. Secondary states are more common 
than primary ones and include external factors destroying 
limbal stem cells, such as chemical or thermal injuries, 
Stevens-Johnson syndrome, ocular cicatricial pemphi-
goid, multiple surgeries or cryotherapies, contact lens 
overuse, or extensive microbial infection [2, 3, 6, 7]. The 
most common among the acquired states are chemical 
or thermal injuries due to alkali or acid compounds [8]. 
As proposed by Kenyon and Tseng, in patients with total 
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limbal stem cell deficiency, limbal autograft or allograft 
transplantation are indicated for corneal surface recon-
struction. This may be combined with or followed by ker-
atoplasty and/or amniotic membrane transplantation [9]. 
Conjunctival autograft (CAU) or conjunctival limbal 
autograft (CLAU) could be considered [8]. In cases of 
bilateral disease where limbal stem cell autografting is 
precluded, the only option for stem cell restoration is the 
use of allogeneic sources [10, 11]. These sources include 
cadaveric keratolimbal allograft (KLAL), living-related 
conjunctival limbal allograft (lr CLAL), and ex vivo stem 
cell allograft expansion [12]. 
MATERIALS AND METHODS 
A 50-year-old woman presented with ocular acid 
burn on both eyes in September 2008. The average time 
between first presentation and the initial burn was al-
most six months. She had a medical history of diabetes 
mellitus type II and was under insulin treatment. Visual 
acuity was counting fingers at 30 cm on the right eye 
and counting fingers at 1 m Snellen line on the left. The 
intraocular pressure was 11 mm Hg on the right eye 
and 14 mm Hg on the left with Goldmann applanation 
tonometry. Slit lamp examination revealed no lid abnor-
malities or formation of symblepharon between surfaces 
of the palpebral and bulbar conjunctiva. The cornea was 
opacified and the conjunctival epithelium covered the 
anterior surface of the cornea due to extensive stem cell 
deficiency. Also there was superficial and deep corneal 
vascularisation (270° on the right and one 180° on the 
left) with vessels extending almost 5 mm from the limbus 
into the centre of the cornea (Fig. 1). Papillary reflexes 
were normal. Fundus was normal on both eyes, although 
fundoscopy was difficult due to corneal opacification; 
therefore, the use of limbal stem cell autografts was not 
possible, and lr CLAL on the right eye was performed. 
HLA typing was used in order to choose the ideal 
living-related donor to prevent stem cell rejection. The 
sister of the patient was the best living HLA- matched 
donor. Both of her eyes were evaluated to ensure there 
was no underlying ocular history and the non-dominant 
eye (the left one) was chosen for the donation. In order to 
exclude the presence of glaucoma, the donor underwent 
evaluation of the optic nerves with OCT and tonometry, 
which were normal. Also she was screened for blood-
borne diseases (hepatitis B and C) and immunodeficiency 
virus (HIV). 
Prior to the operation, the nature of the surgical pro-
cedure and all surgical risks were explained to the patient 
and the donor and informed consents were signed by 
both of them. The donor was operated using retrobulbar 
anesthesia and sedation whereas the patient was operated 
under general anaesthesia. Surgery on the recipient was 
performed following surgery on the donor. 
SURGICAL TECHNIQUE 
Surgery was performed by the second author Dr. 
Ioannis A. Mallias. On the donor’s left eye the sites for 
donation were marked with a gentian violet pen and in-
corporated within the donor tissue. Two separate limbal 
allografts (mean length of 2–3 clock hours) were resected 
from the 12 o’clock and 6 o’clock areas. The posterior 
edge was cut 5 mm posterior to the limbus and the tissue 
was reflected on to the corneal surface. The remaining 
conjunctiva of the donor was anchored to the sclera 
with two 8-0 Vicryl sutures with instillation of a steroid 
antibiotic ointment, and the eye was patched until the 
following day. 1:10,000 topical epinephrine was used for 
haemostasis. A 360° limbal conjunctival peritomy was 
performed. Recipient beds of three clock hours at the 
12 and 6 o’clock meridian and to 5 mm behind the lim-
bus were created, and the abnormal corneal epithelium 
and vascularised pannus were removed. 
The harvested allografts were then transferred to cor-
responding anatomic positions on the recipients with 
the limbal edge at the recipient limbus and secured with 
10-0 nylon sutures. Extensive care was taken to suture the 
grafts properly (not upside down) and to make sure that 
the limbal edge of the graft was sutured on the limbal site 
of the recipient. At the end of the procedure, a steroid 
antibiotic ointment was instilled and the eye was patched 
until the following day [12]. Postoperatively, the donor 
received antibiotic and steroid drops four times daily. The 
FIGURE 1. View of the anterior segment of the patient on initial 
examination: A. Right eye: conjuctivalisation of the cornea with 
270° superficial and deep corneal vascularisation, B. Left eye: 
conjunctival epithelium covering the cornea with 180° vascular-
isation
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former were used for five days and the latter were grad-
ually tapered over a period of three weeks. The recipient 
was managed postoperatively with topical and systemic 
treatment. Topical treatment included dexamethasone so-
dium phosphate (0.1%), ofloxacin (0.5%), and preserva-
tive-free tear supplements, each four times daily. Topical 
corticosteroids were gradually tapered over a period of 
four months, and topical antibiotics were discontinued 
two weeks after surgery. However, tear supplements were 
maintained and the eye was patched all the time for 
twenty days, and it was only opened in order to instil the 
drops. Systemic treatment included immunosuppression 
with steroids and cyclosporine A. Intravenous methyl 
prednisolone 2 mg/kg/day was commenced on the day 
of surgery and maintained for three additional days. Oral 
prednisolone 1 mg/kg/day was then started for one week 
and tapered over two months and systemic cyclosporin 
A 4mg/kg/day separated in two doses per day was admin-
istered for one year. While on treatment, the patient was 
followed by her rheumatologist for possible side effects 
of the systemic immunosuppression, and she underwent 
periodic evaluation of creatinine and blood pressure. 
RESULTS 
The keratolimbal allografts were vascularised nor-
mally during the first postoperative days without signs 
of tissue necrosis or rejection. The cornea of the right 
eye achieved reepithelialisation within two weeks after 
surgery. The epithelial healing was complete with nor-
mal corneal epithelium and no fluorescent staining was 
observed. In eight weeks’ time, there was regression of 
peripheral neovascularisation on the right eye (Fig. 2). 
The cornea was covered with normal corneal epithelium, 
but there was significant haziness of the corneal stroma 
which limited the best corrected visual acuity (BCVA) 
to 20/200 Snellen line. After one year of regular follow 
up, the corneal surface remained stable and no vascular-
isation of the peripheral cornea was observed. However, 
the stroma was opaque and the visual acuity had no 
further improvement. In order to improve the vision, the 
patient underwent penetrating keratoplasty on the same 
eye in October 2009. The surgery was performed under 
general anaesthesia and 8-mm trephination of the host 
cornea was done during the operation. Then 8.25 mm 
trephination of the donor cornea was performed and the 
donor button was secured in the host bed with sixteen 
interrupted 10-0 nylon sutures (Fig. 3). 
Postoperatively, the patient received ofloxacin drops 
(0.5%) four times a day for two weeks and topical cor-
ticosteroids (dexamethasone sodium phosphate month). 
Oral cyclosporine A (4 mg/kg/day) was also administered 
for six months. Additionally, regular corneal topogra-
phies were performed in order to assess the postopera-
tive astigmatism. Selective suture removal started after 
the completion of the third postoperative month. The 
graft remained clear with normal corneal epithelium dur-
ing the follow-up period, which was four years (Fig. 4). 
The Snellen visual acuity was 20/50 with spectacles and 
20/30 with gas permeable contact lenses. 
DISCUSSION 
The appropriate management of a patient with severe 
stem cell deficiency due to chemical burn requires careful 
assessment of factors such as laterality of disease, severity 
of the injury, and presence of conjunctival inflammation. 
When the ocular surface injury is unilateral and there 
is total stem cell deficiency, then a keratolimbal autograft 
FIGURE 2. View of the right eye of the patient eight weeks after 
living-related limbal allograft transplantation. Regression of pe-
ripheral neovascularisation: A. Superior keratolimbal allograft,  
B. Inferior keratolimbal allograft
FIGURE 3. View of the right eye one week after penetrating 
keratoplasty. The cornea is clear, covered with normal corneal 
epithelium with no signs of allograft rejection
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from the healthy fellow eye is the most suitable treatment 
option. This treatment option can be combined with 
the use of an amniotic membrane. However, the worst 
prognostic category is bilateral limbal stem cell deficiency 
accompanied by conjunctival inflammation, such as in 
our case. The first choice of treatment in these patients is 
lr CLAL. If a living relative is not available, then KLAL is 
the next option. Ex vivo stem cell expansion may also be 
employed in such cases [13]. Evaluating the technique of 
lr CLAL, there is the advantage of providing some degree 
of immune histocompatibility [12, 14, 15]. Therefore, 
the possibility of graft rejection is much lower as well as 
the need for systemic immunosuppression. Furthermore, 
there is a reduction of the cell death rate due to obvious 
disadvantages in using living related limbal allografts 
because limbal allografting is limited by the amount of 
tissue that can be transplanted. In particular, a superior 
limbal graft length of five or six clock hours is a limitation 
in order to protect the donor’s eye [12, 16]. Whereas, in 
KLAL a complete limbus for transplantation and thus 
a larger load of stem cells with restoration of a barrier 
to the whole limbus can be obtained from a cadaveric 
donor [13]. 
The chemical burn of our patient was bilateral and the 
consequent stem cell deficiency was total. She underwent 
an lr CLAL on her right eye with two limbal grafts from 
her sister’s eye, who was the best living HLA-matched 
donor. The grafts were protected by systemic immu-
nosuppression with steroids and cyclosporine A. With 
this procedure the corneal epithelium was reconstructed 
and the visual acuity was improved. After a five-year fol-
low-up, no graft rejection occurred, although the patient 
was under systemic immunosuppression only for the first 
year. However, Huang et al. [17] reported that partial 
limbal stem cell deficiency may be the best indication for 
lr CLAL, because even if graft rejection were to occur, the 
amount of residual stem cells would be able to sustain 
sufficient epithelial cell production. They performed this 
procedure in eyes with partial limbal deficiency (< 50%) 
secondary to ocular chemical burns. However, they did 
not administer systemic immunosuppression with cyclo-
sporine A, but they accomplished a lower rejection rate 
compared with rejection rates of other studies. Converse-
ly, Rao et al. [16] and Daya et al. [15] emphasised the 
importance of immunosuppression, stating that systemic 
immunosuppressants are necessary even if the donors are 
compatible to recipients. 
As far as HLA compatibility is concerned, Kwitko et 
al. [14] reported that HLA matched limbal allograft trans-
plantation provides long-term graft survival and minimis-
es the rate of graft rejection. The importance of a good 
HLA matching is also highlighted by Daya et al. [15] 
and other studies [11]. Whereas, the Collaborative Cor-
neal Transplantation Studies Research Group demon-
strated that HLA antigen matching does not ensure the 
survival of corneal graft in high-risk corneal transplan-
tation [18]. 
An alternative option to limbal allograft transplan-
tation is the Cincinnati procedure performed by Biber 
et al. [19]. In this procedure, patients with severe ocular 
surface disease and conjunctival deficiency underwent 
combined lr CLAL and KLAL and achieved significant 
improvement in visual acuity. 
A study conducted by Sonmez et al. [20] is also worth 
mentioning. In this study, they performed either KLAL 
combined with lr CLAL or KLAL alone, using only 
fibrin sealant in order to secure the allografts to the recip-
ient’s ocular surface without sutures. They reported that 
the use of fibrin tissue glue decreased the operation time 
and suture-related complications such as postoperative 
inflammation and graft rejection. In our case, although 
we used sutures to secure the allografts to the recipient’s 
eye, we did not observe excessive inflammation or graft 
rejection. Moreover, we achieved a five-year survival of 
the limbal allografts by using good HLA matching and 
systemic immunosuppression. Hence, we would like to 
emphasise the importance of these two factors in the 
long-term survival of limbal allografts, especially in cases 
of total limbal stem cell deficiency. 
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